Back to Journals » Therapeutics and Clinical Risk Management » Volume 5
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Role of combination bortezomib and pegylated liposomal doxorubicin in the management of relapsed and/or refractory multiple myeloma
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
32,261 | Dovepress* | 32,261+ | 1,902 | 34,163 | |
Totals | 32,261 | 1,902 | 34,163 | ||
*Since 22 January 2009 +Since July 2016 |
View citations on Google Scholar